A panel of 10 expert hematologists created recommendations for optimal MRD-guided ALL treatment, which were recently ...

This Double Take video from the New England Journal of Medicine describes a man with recurrent severe diffuse abdominal pain without obvious associated symptoms. Based on a Clinical Problem ...

Blinatumomab 的商品名是Blincyto，俗称blina，是一种生物制药药物，用于治疗费城染色体阴性的复发或难治性急性淋巴细胞白血病的二线治疗。它属于一类合成单克隆抗体，即双特异性 T 细胞接合器(BiTE)，可选择性地发挥作用并指示人体免疫系统对抗肿瘤细胞。

NEW YORK – The UK's National Institute for Health and Care Excellence (NICE) on Friday approved Amgen's Blincyto (blinatumomab) with chemotherapy as a consolidation treatment for adult patients with ...

Separately, NICE has also recommended the use of Blincyto (blinatumomab), a bispecific T-cell engager (BiTE) therapy from Amgen. The treatment is for adults with CD19-positive B-cell precursor acute ...